Clinical Trials Logo

Colonic Neoplasms clinical trials

View clinical trials related to Colonic Neoplasms.

Filter by:

NCT ID: NCT01012362 Terminated - Breast Cancer Clinical Trials

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Start date: December 2009
Phase: Phase 1
Study type: Interventional

This is a Phase I study; dose escalating the combination of pazopanib when taken daily and ixabepilone when administered on day 1 of a 3 week treatment course.

NCT ID: NCT01011478 Terminated - Colorectal Cancer Clinical Trials

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Start date: March 2010
Phase: Phase 3
Study type: Interventional

RATIONALE: Rosuvastatin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving rosuvastatin after surgery may kill any tumor cells that remain after surgery. It may also keep polyps from forming or colon cancer from coming back. It is not yet known whether rosuvastatin is more effective than a placebo in treating colon cancer that was removed by surgery. PURPOSE: This randomized phase III trial is studying rosuvastatin to see how well it works compared with placebo in treating patients with stage I or stage II colon cancer that was removed by surgery.

NCT ID: NCT00997802 Completed - Colonic Neoplasms Clinical Trials

Japanese National Computed Tomographic (CT) Colonography Trial

JANCT
Start date: October 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the sensitivity of computed tomographic colonography (CTC) in detecting colorectal polyps and cancers in 1,500 subjects at increased risk of colorectal cancer (CRC), using optical colonoscopy as the reference standard.

NCT ID: NCT00994864 Completed - Colon Cancer Clinical Trials

Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer

PePiTA
Start date: November 2009
Phase: N/A
Study type: Interventional

The primary working hypothesis is that preoperative chemo-sensitivity testing using fluorodeoxyglucose positron emission tomography (FDG-PET) performed before and after one course of FOLFOX (folinic acid, fluorouracil, oxaliplatin) can identify the patients that will least likely have a significant benefit from adjuvant FOLFOX for stage III colon cancer. The benefit will be analyzed by correlating the preoperative FDG-PET uptake changes to the disease free and overall survival.

NCT ID: NCT00985400 Active, not recruiting - Colorectal Cancer Clinical Trials

Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery

Start date: November 5, 2010
Phase: N/A
Study type: Interventional

The goal of this study is to compare the effects of exercise with the effects of relaxation training on physical function (how well participants perform normal daily activities) and symptoms related to your cancer diagnosis (such as tiredness, pain, and nausea).

NCT ID: NCT00969046 Completed - Colon Cancer Clinical Trials

Dose-Escalation Study in Advanced Colon Cancer Patients

Start date: November 2003
Phase: Phase 1
Study type: Interventional

This study is exploring different administration schedules (short versus prolonged infusion) to optimize the safety and efficacy profile of EPO906A (patupilone) in patients with pretreated advanced colon cancer.

NCT ID: NCT00967148 Completed - Cancer Clinical Trials

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer

PERI-OP
Start date: June 2009
Phase: N/A
Study type: Interventional

The blood thinner "tinzaparin" might increase survival in patients with colon cancer undergoing surgical resection. The investigators want to assess if a trial allocating patients to prolonged treatment with tinzaparin versus standard of care is feasible.

NCT ID: NCT00958737 Active, not recruiting - Colorectal Cancer Clinical Trials

Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer

IDEA
Start date: May 12, 2009
Phase: Phase 3
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether giving more than one drug (combination chemotherapy) is more effective when given for 3 months or 6 months in treating patients with colon cancer. PURPOSE: This randomized phase III trial is studying giving combination chemotherapy for 3 months to see how well it works compared with giving combination chemotherapy for 6 months in treating patients with stage III colon cancer.

NCT ID: NCT00949312 Active, not recruiting - Colorectal Cancer Clinical Trials

Studying Lymph Nodes in Patients With Stage II Colon Cancer

Start date: May 2009
Phase:
Study type: Observational

RATIONALE: Diagnostic procedures that look for micrometastases in lymph nodes removed during surgery for colon cancer may help doctors learn the extent of disease. PURPOSE: This phase I trial is studying lymph nodes in patients with stage II colon cancer.

NCT ID: NCT00932438 Completed - Clinical trials for Colon Cancer With Metastases to the Liver

Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab

DEBIRI
Start date: June 2009
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicentre, open labeled, controlled phase study designed to assess effectiveness of chemoembolization with LC Beads, both with and without systemic chemotherapy, in the treatment of unresectable liver metastases in patients with colorectal cancer.